Eli Lilly Just Announced Something Big. Here’s What It Means for Investors.
The company is the leader in a key growth market.
Overview
Eli Lilly (NYSE:LLY) has been making the headlines for one particular reason over the last few years. It dominates in an area that has captured the general public's attention: weight loss drugs. Lilly sells injectable GLP-1 drugs Mounjaro and Zepbound, and they've been generating blockbuster revenue -- and the company's recent launch of weight loss pill, Foundayo, opens up yet another valuable opportunity in this billion-dollar market.
But Lilly isn't stopping there. The pharma giant just announced something big. Let's find out what it means for you as an investor.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.